ALNY241018C320000
- 0.86
- 0.000.00%
Alnylam Pharmaceuticals Newsroom
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $307
Alnylam Pharmaceuticals Price Target Maintained With a $300.00/Share by RBC Capital
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating
TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $282
TD Cowen Sticks to Their Buy Rating for Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Alnylam Pharmaceuticals, Maintains $220 Price Target
Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $260
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $400
B of A Securities Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $307
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $282 to $295
Alnylam Pharma (ALNY) Gets a Buy From TD Cowen
Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $295
Alnylam Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400